Study first to connect stress-associated brain activity with cardiovascular risk

January 11, 2017
Credit: Tawakol et al, 2017, The Lancet

A study led by Massachusetts General Hospital (MGH) and Icahn School of Medicine at Mount Sinai (ISSMS) investigators has linked, for the first time in humans, activity in a stress-sensitive structure within the brain to the risk of subsequent cardiovascular disease. The team's findings, being published in the journal The Lancet, also reveals a pathway leading from activation of that structure—the amygdala—through elevated immune system activity to an increased incidence of cardiovascular events.

"While the link between and heart disease has long been established, the mechanism mediating that risk has not been clearly understood," says Ahmed Tawakol, MD, co-director of the Cardiac MR PET CT Program in the MGH Division of Cardiology and lead author of the paper. "Animal studies have shown that stress activates bone marrow to produce white blood cells, leading to arterial inflammation, and this study suggests an analogous path exists in humans. Moreover, this study identifies, for the first time in animal models or humans, the region of the brain that links stress to the risk of heart attack and stroke."

The paper reports on two complementary studies. The first, conducted at MGH, analyzed imaging and medical records data from almost 300 individuals who had PET/CT brain imaging, primarily for cancer screening, using a radiopharmaceutical called FDG that both measures the activity of areas within the brain and also reflects inflammation within arteries. All participants in that study had no active cancer or at the time of imaging and each had information in their medical records on at least three additional clinical visits in the two to five years after imaging. The second study, conducted at the Translational and Molecular Imaging Institute (TMII) at ISMMS in New York, enrolled 13 individuals with a history of , who were evaluated for their current levels of perceived stress and received FDG-PET scanning to measure both amygdala activity and arterial inflammation.

Among participants in the larger, longitudinal study, 22 experienced a cardiovascular event—such as a heart attack, stroke or episodes of angina—in the follow-up period; and the prior level of activity in the amygdala strongly predicted the risk of a subsequent cardiovascular event. That association remained significant after controlling for traditional , and after controlling for presence of symptom-free atherosclerosis at the time of imaging. The association became even stronger when the team used a more stringent definition of cardiovascular events—major .

Amygdalar activity was also associated with the timing of events, as those with the highest levels of activity had events sooner than those with less extreme elevation, and greater amygdalar activity was also linked to elevated activity of the blood-cell-forming tissue in the bone marrow and spleen and to increased arterial inflammation. In the smaller study, participants' current stress levels were strongly associated with both amygdalar activity and arterial inflammation.

Co-senior author Zahi A. Fayad, PhD, vice-chair for Research in the Department of Radiology and the director of TMII at ISMMS in New York, says, "This pioneering study provides more evidence of a heart-brain connection, by elucidating a link between resting metabolic activity in the amygdala, a marker of stress, and subsequent independently of established cardiovascular risk factors. We also show that amygdalar activity is related to increased associated perceived stress and to an increased vascular inflammation and hematopoeitic activity."

Tawakol adds, "These findings suggest several potential opportunities to reduce cardiovascular risk attributable to stress. It would be reasonable to advise individuals with increased risk of cardiovascular disease to consider employing stress-reduction approaches if they feel subjected to a high degree of psychosocial stress. However, large trials are still needed to confirm that stress reduction improves . Further, pharmacological manipulation of the amygdalar-bone marrow-arterial axis may provide new opportunities to reduce cardiovascular disease. In addition, increased stress associates with other diseases, such as cancer and inflammatory conditions, including rheumatoid arthritis and psoriasis. So it will be important to evaluate whether calming this stress mechanism produces benefits in those diseases as well."

Explore further: Signs of stress in the brain may signal future heart trouble

More information: The Lancet, DOI: 10.1016/S0140-6736(16)31714-7, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31714-7/fulltext

Related Stories

Signs of stress in the brain may signal future heart trouble

March 24, 2016
New research shows that individuals with a greater degree of activity in the stress center of the brain also have more evidence of inflammation in their arteries and were at higher risk for cardiovascular events, including ...

Review links anxiety disorders to risk of cardiovascular events

August 15, 2016
(HealthDay)—Anxiety disorders are associated with a range of cardiovascular events, according to a meta-analysis published in the Aug. 15 issue of The American Journal of Cardiology.

Cardiovascular event risk of RA patients comparable to type-2 diabetes over 15-year period

November 13, 2016
Rheumatoid arthritis is associated with serious risk of cardiovascular (CV) disease events such as heart attack or stroke. Over a 15-year period, people with RA may have double the risk of CV events as those in the general ...

Antiretroviral therapy may not be enough to reduce HIV-associated arterial inflammation

May 25, 2016
Initiating antiretroviral therapy (ART) soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in a small group of previously untreated patients. The findings from a ...

Being fit protects against health risks caused by stress at work

November 1, 2016
It is a well-known fact that fitness and well-being go hand in hand. But being in good shape also protects against the health problems that arise when we feel particularly stressed at work. As reported by sports scientists ...

Study links depression to arterial stiffness during stress

March 14, 2014
(Medical Xpress)—According to a study by researchers at Emory's Rollins School of Public Health, symptoms of depression are associated with an increase in arterial stiffness induced by mental stress. Arterial stiffness ...

Recommended for you

Metabolism switch signals end for healing hearts

September 19, 2017
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it.

Beta blockers not needed after heart attack if other medications taken

September 18, 2017
A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge ...

Which single behavior best prevents high blood pressure?

September 15, 2017
(HealthDay)—You probably already know that certain healthy lifestyle behaviors can reduce your risk of developing high blood pressure, but is any one behavior more important than the others?

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke

September 13, 2017
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial ...

Study shows so-called 'healthy obesity' is harmful to cardiovascular health

September 11, 2017
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities such as diabetes.

Statins reduce deaths from heart disease by 28 percent in men with high LDL levels, says longest ever study

September 6, 2017
Previous research has shown the benefit of statins for reducing high cholesterol and heart disease risk amongst different patient populations. However, until now there has been no conclusive evidence from trials for current ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.